Predict your next investment

Cochlear company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
cochlear.com

See what CB Insights has to offer

Investments

7

Portfolio Exits

1

Partners & Customers

8

Service Providers

1

About Cochlear

Cochlear provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses.

Cochlear Headquarter Location

1 University Avenue Macquarie University

Macquarie University, New South Wales, 2109,

Australia

61 2 9428 6555

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cochlear

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Cochlear in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Cochlear Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cochlear Rank

Latest Cochlear News

Global Hearing Aids Market to Garner USD 12 Billion in 2031 and to Grow with a CAGR of ~ 7% during 2022-2031; Market to Grow on Account of Rising Incidences of Hearing Loss and Increased Levels of Noise Exposure - Kenneth Research

Aug 10, 2022

Key Companies Compiled in the Global Hearing Aids Market Research Report by Kenneth Research Include Sonava, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD., Audina Hearing Instruments, Inc., and others. Key Companies Compiled in the Global Hearing Aids Market Research Report by Kenneth Research Include Sonava, Demant A/S, GN Store Nord A/S, WS Audiology A/S, Starkey Laboratories, Inc., MED-EL Medical Electronics, Cochlear Ltd., RION CO., LTD., Audina Hearing Instruments, Inc., and others.

Cochlear Investments

7 Investments

Cochlear has made 7 investments. Their latest investment was in Epiminder as part of their Bridge on March 3, 2022.

CBI Logo

Cochlear Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/15/2022

Bridge

Epiminder

$11.5M

No

1

10/14/2021

Corporate Minority

Subscribe to see more

$99M

Subscribe to see more

10

8/26/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

10/9/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/12/2018

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/15/2022

10/14/2021

8/26/2021

10/9/2020

11/12/2018

Round

Bridge

Corporate Minority

Series A

Series A

Series C

Company

Epiminder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$11.5M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

Cochlear Portfolio Exits

1 Portfolio Exit

Cochlear has 1 portfolio exit. Their latest portfolio exit was Nyxoah on September 09, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/9/2020

IPO

$99M

Public

5

Date

9/9/2020

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

5

Cochlear Acquisitions

2 Acquisitions

Cochlear acquired 2 companies. Their latest acquisition was Oticon Medical on April 27, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/27/2022

$99M

Acquired

3

5/11/2017

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/27/2022

5/11/2017

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired

Subscribe to see more

Sources

3

10

Cochlear Partners & Customers

8 Partners and customers

Cochlear has 8 strategic partners and customers. Cochlear recently partnered with GN Group on November 11, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

11/8/2018

Partner

Denmark

Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions

The deepening of this relationship includes joint research and development , shared technology and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear Limited and GN Hearing , the hearing aid division of the GN Hearing .

6

4/12/2018

Licensor

France

Subscribe to see more

Subscribe to see more

10

7/26/2017

Partner

United States

Subscribe to see more

Subscribe to see more

10

12/22/2016

Partner

Denmark

Subscribe to see more

Subscribe to see more

10

1/1/2015

Partner

Denmark

Subscribe to see more

Subscribe to see more

10

Date

11/8/2018

4/12/2018

7/26/2017

12/22/2016

1/1/2015

Type

Partner

Licensor

Partner

Partner

Partner

Business Partner

Country

Denmark

France

United States

Denmark

Denmark

News Snippet

Cochlear and GN Hearing Strengthen Technology and Commercial Alliance to Develop Best-in-Class Integrated Hearing Solutions

The deepening of this relationship includes joint research and development , shared technology and strengthened global Smart Hearing Alliance commercial collaboration between Cochlear Limited and GN Hearing , the hearing aid division of the GN Hearing .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

10

10

10

10

Cochlear Service Providers

1 Service Provider

Cochlear has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acquired

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Cochlear Team

11 Team Members

Cochlear has 11 team members, including former Chief Executive Officer, President, Ron West.

Name

Work History

Title

Status

Ron West

Chief Executive Officer, President

Former

David Morris

President, Senior Vice President

Former

John Parker

NICTA

Chief Technology Officer

Former

Peter C Weber

Chief Medical Officer

Former

Lisa Emerson

Senior Vice President

Former

Name

Ron West

David Morris

John Parker

Peter C Weber

Lisa Emerson

Work History

NICTA

Title

Chief Executive Officer, President

President, Senior Vice President

Chief Technology Officer

Chief Medical Officer

Senior Vice President

Status

Former

Former

Former

Former

Former

You May Also Like

Zounds Hearing Logo
Zounds Hearing

Zounds designs, manufactures, and markets high performance hearing aids for use with mild, moderate, and moderate/severe hearing impairments. Zounds' goal is to offer a portfolio of hearing aids and wireless devices that provide the world's best performing technology at an affordable price to anyone with a mild, moderate, or moderate/severe hearing loss.

A
Audigence

Audigence has developed patented software that better tunes cochlear implant and hearing aids for clearer speech recognition in hearing-impaired individuals.

V
Vast Audio

VAST Audio leverages its acoustics platform technology to develop DSP technologies involving the application of advanced sensory processing techniques to 3D hearing devices. The Company is developing a spatial hearing aid to effectively support listening in both noisy and quiet environments. The hearing aid is based on the company's Completely-in-Canal (CIC) earphone and aims to provide the perceptual basis for segregating talkers in noisy environments and will lead to vast improvement in speech segregation and intelligibility.

A
Accord BioMaterials

Accord Biomaterials aims to develop nitric oxide generating coatings for blood-contacting medical devices. Their coatings address serious complications related to clotting and altered healing, improving performance and reducing total costs of critical medical device interventions.

K
Kyphon

Kyphon develops and markets medical devices designed to restore spinal function using minimally invasive technologies. The company's KyphX(R) line of products is used in balloon kyphoplasty, a minimally invasive procedure to treat spinal fractures caused by osteoporosis or cancer. More information about the company can be found at www.kyphon.com.

G
GN Group

The GN Group is a global leader in intelligent audio solutions that let you hear more, do more and be more than you ever thought possible. Its unique portfolio of medical, professional & consumer audio solutions – and the deep research & development expertise behind this range of products gives our brands unprecedented advantages in the med-tech, hearables and intelligent audio field.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.